Research ArticleOriginal Article
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
Zhen Zhou, Zichuan Liu, Qiuxiang Ou, Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu and Yu Yang
Cancer Biology & Medicine May 2021, 18 (2) 490-501; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0120
Zhen Zhou
1Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
Zichuan Liu
2Section No. 2 Internal Medicine, Cancer Center of Guangzhou Medical University, Guangzhou 511436, China
Qiuxiang Ou
3Translational Medicine Research Institute, Geneseeq Technology Inc., Toronto M5G1L7, Canada
Xue Wu
3Translational Medicine Research Institute, Geneseeq Technology Inc., Toronto M5G1L7, Canada
Xiaonan Wang
4Nanjing Geneseeq Technology Inc., Nanjing 211500, China
Yang Shao
3Translational Medicine Research Institute, Geneseeq Technology Inc., Toronto M5G1L7, Canada
5School of Public Health, Nanjing Medical University, Nanjing 211166, China
Hongyan Liu
6Department of Respiratory Medicine, The Second Hospital of Anhui Medical University, Hefei 230031, China
Yu Yang
7Department of Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin 150086, China
References
- 1.↵
- 2.↵
- Presta M,
- Chiodelli P,
- Giacomini A,
- Rusnati M,
- Ronca R.
- 3.↵
- Hubbard SR,
- Till JH.
- 4.↵
- Haugsten EM,
- Wiedlocha A,
- Olsnes S,
- Wesche J.
- 5.↵
- Desai A,
- Adjei AA.
- 6.↵
- Perera TPS,
- Jovcheva E,
- Mevellec L,
- Vialard J,
- De Lange D,
- Verhulst T, et al.
- 7.↵
- Tabernero J,
- Bahleda R,
- Dienstmann R,
- Infante JR,
- Mita A,
- Italiano A, et al.
- 8.↵
- 9.↵
- Bellmunt J,
- Theodore C,
- Demkov T,
- Komyakov B,
- Sengelov L,
- Daugaard G, et al.
- 10.
- McCaffrey JA,
- Hilton S,
- Mazumdar M,
- Sadan S,
- Kelly WK,
- Scher HI, et al.
- 11.↵
- Vaughn DJ,
- Broome CM,
- Hussain M,
- Gutheil JC,
- Markowitz AB.
- 12.↵
- Tiseo M,
- Gelsomino F,
- Alfieri R,
- Cavazzoni A,
- Bozzetti C,
- De Giorgi AM, et al.
- 13.↵
- Liao RG,
- Jung J,
- Tchaicha J,
- Wilkerson MD,
- Sivachenko A,
- Beauchamp EM, et al.
- 14.↵
- 15.↵
- Yang Z,
- Yang N,
- Ou Q,
- Xiang Y,
- Jiang T,
- Wu X, et al.
- 16.↵
- Bolger AM,
- Lohse M,
- Usadel B.
- 17.↵
- Koboldt DC,
- Zhang Q,
- Larson DE,
- Shen D,
- McLellan MD,
- Lin L, et al.
- 18.↵
- 19.↵
- Chakravarty D,
- Gao J,
- Phillips S,
- Kundra R,
- Zhang H,
- Wang J, et al.
- 20.↵
- 21.↵
- Jain P,
- Surrey LF,
- Straka J,
- Luo M,
- Lin F,
- Harding B, et al.
- 22.↵
- Gao L,
- Wang X,
- Tang Y,
- Huang S,
- Hu CA,
- Teng Y.
- 23.↵
- Zhang X,
- Kong M,
- Zhang Z,
- Xu S,
- Yan F,
- Wei L, et al.
- 24.↵
- Helsten T,
- Elkin S,
- Arthur E,
- Tomson BN,
- Carter J,
- Kurzrock R.
- 25.↵
- Reck M,
- Kaiser R,
- Mellemgaard A,
- Douillard JY,
- Orlov S,
- Krzakowski M, et al.
- 26.↵
- Abou-Alfa GK,
- Sahai V,
- Hollebecque A,
- Vaccaro G,
- Melisi D,
- Al-Rajabi R, et al.
- 27.↵
- Hashemi-Sadraei N,
- Hanna N.
- 28.↵
- Singleton KR,
- Hinz TK,
- Kleczko EK,
- Marek LA,
- Kwak J,
- Harp T, et al.
- 29.
- Weeden CE,
- Solomon B,
- Asselin-Labat ML.
- 30.↵
- Wynes MW,
- Hinz TK,
- Gao D,
- Martini M,
- Marek LA,
- Ware KE, et al.
- 31.↵
- Packer LM,
- Geng X,
- Bonazzi VF,
- Ju RJ,
- Mahon CE,
- Cummings MC, et al.
- 32.↵
- Wheler JJ,
- Atkins JT,
- Janku F,
- Moulder SL,
- Stephens PJ,
- Yelensky R, et al.
- 33.↵
- Wang R,
- Wang L,
- Li Y,
- Hu H,
- Shen L,
- Shen X, et al.
- 34.↵
- Wu YM,
- Su F,
- Kalyana-Sundaram S,
- Khazanov N,
- Ateeq B,
- Cao X, et al.
- 35.↵
- Ou SI,
- Horn L,
- Cruz M,
- Vafai D,
- Lovly CM,
- Spradlin A, et al.
- 36.↵
- Reis-Filho JS,
- Simpson PT,
- Turner NC,
- Lambros MB,
- Jones C,
- Mackay A, et al.
- 37.↵
- Gao L,
- Lang L,
- Zhao X,
- Shay C,
- Shull AY,
- Teng Y.
In this issue
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
Zhen Zhou, Zichuan Liu, Qiuxiang Ou, Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu, Yu Yang
Cancer Biology & Medicine May 2021, 18 (2) 490-501; DOI: 10.20892/j.issn.2095-3941.2020.0120
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
Zhen Zhou, Zichuan Liu, Qiuxiang Ou, Xue Wu, Xiaonan Wang, Yang Shao, Hongyan Liu, Yu Yang
Cancer Biology & Medicine May 2021, 18 (2) 490-501; DOI: 10.20892/j.issn.2095-3941.2020.0120
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.